Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,098 public trials 1,201 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

NCT06375915

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: ASST Papa Giovanni XXIII Bergamo, Bg, Italy

Azienda Ospedaliero Universitaria Pisana Pisa, Pi, Italy

Department of Radiology, IRCCS Ospedale San Raffaele Milan, Italy

Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli Naples, Italy

View Trial Details

Recruiting

Real-world Insight Into Systemic Therapies for HCC: Single-center Study

NCT07814014

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Mansoura University Hospitals Al Mansurah, Dakahlia Governorate, Egypt

View Trial Details

Recruiting

Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function

NCT07811687

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China

View Trial Details

Recruiting

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

NCT06037980

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
Locations: Ospedali Riuniti di Ancona Ancona, Italy

ASST Papa Giovanni XXIII Bergamo, Italy

Oncologia Medica Policlinico Sant'Orsola - Malpighi Bologna, Italy

ASST Spedali Civili Brescia, Italy

View all 19 locations

View Trial Details

Recruiting

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NCT06175845

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +20 more
Locations: University Medical Center Hamburg-Eppendorf Hamburg, Germany

Charite Berlin, Germany

University Medical Center Bonn, Germany

Clinic Chemnitz Chemnitz, Germany

View Trial Details

Recruiting

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +28 more
Locations: Norton Cancer Institute PARENT Louisville, Kentucky, United States

START Midwest Grand Rapids, Michigan, United States

Carolina BioOncology Institute, LLC Huntersville, North Carolina, United States

Rhode Island Hospital East Providence, Rhode Island, United States

View Trial Details

Recruiting

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

NCT07162480

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations: University Of Iowa Iowa City, Iowa, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Corewell Health William Beaum Hosp Royal Oak, Michigan, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations: Stanford Palo Alto, California, United States

Washington University in St. Louis St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal

View Trial Details

Recruiting

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

NCT06903468

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details